Significant incidence of braf p.V600E mutations in esophageal cancer sets the stage for potential use of tyrosine kinase inhibitors

Simple item page
dc.contributor.authorRajasooriyar, C.
dc.contributor.authorMoorthy, T.
dc.contributor.authorRanatunge, N.
dc.contributor.authorGinige, A.
dc.contributor.authorSurenthirakumaran, R.
dc.date.accessioned2022-09-26T05:46:35Z
dc.date.available2022-09-26T05:46:35Z
dc.date.issued2020
dc.identifier.citationProceedings JMA-September - 2020en_US
dc.identifier.urihttp://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7607
dc.language.isoenen_US
dc.publisherJaffna Medical Associationen_US
dc.subjectEsophageal canceren_US
dc.subjectTyrosine kinase inhibitorsen_US
dc.subjectMutationen_US
dc.titleSignificant incidence of braf p.V600E mutations in esophageal cancer sets the stage for potential use of tyrosine kinase inhibitorsen_US
dc.typeResearch abstracten_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
OP14.pdf
Size:
459.2 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download

Collections

Community & Family Medicine